GENZYME CORP Investing Cash Flow
GENZYME CORP reported Investing Cash Flow of -$75.34 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2011-03-01
- GENZYME CORP net cash provided by (used in) investing activities for the quarter ending 2010-12-31 was $396.50M.
- GENZYME CORP net cash provided by (used in) investing activities for the quarter ending 2010-09-30 was -$137.77M.
- GENZYME CORP net cash provided by (used in) investing activities for the quarter ending 2010-06-30 was -$149.41M.
- GENZYME CORP net cash provided by (used in) investing activities for the quarter ending 2010-03-31 was -$184.67M.
- GENZYME CORP net cash provided by (used in) investing activities for fiscal 2010 was -$75.34M.
- GENZYME CORP net cash provided by (used in) investing activities for fiscal 2009 was -$671.42M.
- GENZYME CORP net cash provided by (used in) investing activities for fiscal 2008 was -$581.54M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2010-12-31 | $396.50M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $258.73M derived: sum of 2 quarters · filed 2011-03-01 | $109.32M derived: sum of 3 quarters · filed 2011-03-01 | -$75.34M 10-K · filed 2011-03-01 |
| 2010-09-30 | -$137.77M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | -$287.17M derived: sum of 2 quarters · filed 2010-11-09 | -$471.84M 10-Q · filed 2010-11-09 | -$656.18M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | -$149.41M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | -$334.07M 10-Q/A · filed 2010-09-07 | -$518.41M derived: sum of 3 quarters · filed 2011-03-01 | -$627.01M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | -$184.67M 10-Q/A · filed 2010-05-11 | -$369.01M derived: sum of 2 quarters · filed 2011-03-01 | -$477.61M derived: sum of 3 quarters · filed 2011-03-01 | -$744.59M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | -$184.34M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$292.94M derived: sum of 2 quarters · filed 2011-03-01 | -$559.92M derived: sum of 3 quarters · filed 2011-03-01 | -$671.42M 10-K · filed 2011-03-01 |
| 2009-09-30 | -$108.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | -$375.58M derived: sum of 2 quarters · filed 2010-11-09 | -$487.08M 10-Q · filed 2010-11-09 | -$504.89M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | -$266.98M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | -$378.49M 10-Q/A · filed 2010-09-07 | -$396.30M derived: sum of 3 quarters · filed 2011-03-01 | -$607.33M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | -$111.50M 10-Q/A · filed 2010-05-11 | -$129.31M derived: sum of 2 quarters · filed 2011-03-01 | -$340.35M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | -$17.81M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$228.85M derived: sum of 2 quarters · filed 2011-03-01 | -$581.54M 10-K · filed 2011-03-01 | |
| 2008-09-30 | -$211.04M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | -$563.73M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | -$352.69M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | -$591.06M 8-K · filed 2010-06-14 |